NCT00585208View on ClinicalTrials.gov

Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance

PHASE3TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

December 31, 2010

Conditions
InsomniaBipolar Disorder
Interventions
DRUG

Ramelteon

Ramelteon 8mg daily

DRUG

Placebo

matching placebo for ramelteon 8mg daily

Trial Locations (1)

45040

The Lindner Center of HOPE, Mason

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

University of Cincinnati

OTHER

lead

Lindner Center of HOPE

OTHER

NCT00585208 - Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance | Biotech Hunter | Biotech Hunter